China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2012-02-29 01:30 Bicon Pharma Lands $250 Million in PE Capital from PAG Asia 2012-02-28 01:30 Tibet Pharma Plans to End Short Stint as Public Company and more... 2012-02-26 01:30 The Week in Review: Newsummit to Stage $80 Million IPO on NYSE and more... 2012-02-25 01:30 Access Pharma Gains SFDA Approval for Oral Mucositis Treatment and more... 2012-02-24 01:30 China Raises Basic Healthcare Subsidy by 80% 2012-02-23 01:30 Hutchison MediPharma Starts Phase I Trial of Fourth Cancer Molecule and more... 2012-02-22 01:30 Fosun Pharma Invests in Korean IVD Company and more... 2012-02-21 01:30 Pfizer and Zhejiang Hisun to Invest $545 Million in Generic Drug JV 2012-02-19 01:30 The Week in Review: ChinaBioÔö£éÔö¼?½ Partnering Forum 2012 Scheduled for Suzhou 2012-02-18 01:30 Asymchem Opens Large-Scale CMO Facility in Jilin Province and more... 2012-02-17 01:30 ChinaBioÔö£éÔö¼?½ and EBD Schedule ChinaBioÔö£éÔö¼?½ Partnering Forum in May and more... 2012-02-16 01:30 BioDuro Collaborates with Dow to Develop Crop Protection Products 2012-02-15 01:30 China Will Greatly Expand Essential Drug List and more... 2012-02-14 01:30 GSK Devotes Unit to Traditional Chinese Medicine R&D and more... 2012-02-12 01:30 The Week in Review: Fosun Pharma Plans Large Hong Kong IPO 2012-02-11 01:30 Changchun BCHT Biotech Acquires Flu Vaccine Technology 2012-02-10 01:30 Shanghai Pharma to Spend $80 Million on North China Expansion and more... 2012-02-09 01:30 Once Again, Fosun Pharma Plans Hong Kong IPO 2012-02-08 01:30 Shanghai Biochip Signs MOU with GeneNews of Canada and more... 2012-02-07 01:30 Shanghai Pharma Acquires Second API Maker this Year 2012-02-05 01:30 The Week in Review: Are WuXi PharmaTech and ShangPharma Takeover Targets? 2012-02-04 01:30 Steve Yang: AstraZeneca in China Wants to Transform Pharma R&D Models and more... 2012-02-03 01:30 AstraZeneca Pairs 7,300 Job Cuts with China Spending and more... 2012-02-02 01:30 Frontage Labs Completes US Phase I Trial for China TCM Company 2012-02-01 01:30 Beijing FDA Speeds Up its Fast-Track Review   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC